Finzati - Logo
ADIA logo

Adia Med Inc.

ADIA • Medical - Pharmaceuticals
$0.14
▼ -0.01 (-3.57%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 43%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$12.74M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.14
Change-3.57%
Shares Out94.40M
Market Cap$12.74M
Enterprise Value$13.45M
52W Range0.03 - 0.28
Beta-8.23
P/B-33.56
Gross Margin27.36%
Oper. Margin-52.32%
Profit Margin-56.45%
Debt/Eq-2.33

Investment DNA

How strong this company looks for long-term investors

35
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
56/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 4/11/2012
Industry: Medical - Pharmaceuticals
P/B i: -33.56
Debt / Equity i: -2.33
Operating Margin: -52.32%
Net Margin: -56.45%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: -2.33
Current Ratio: 1.11
Quick Ratio: 0.62
Status: Moderate

Warnings

  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

PivX Solutions, Inc.
Transaction: 12/28/2011
BUY
Change
+10,000
Price
$0.03
Filing
01/03/2012
Type
BUY
PivX Solutions, Inc.
Transaction: 12/20/2011
BUY
Change
+16,000
Price
$0.03
Filing
01/03/2012
Type
BUY